| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust developmental portfolio encompasses several promising candidates: ART27.13, a synthetic G protein-coupled receptor agonist currently undergoing Phase 1b/2a clinical investigation for cancer-related anorexia; ART12.11, a synthetic cannabidiol cocrystal being explored for inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, …
Over the last 12 months, insiders at Artelo Biosciences, Inc. have bought $0 and sold $0 worth of Artelo Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Artelo Biosciences, Inc. have bought $9,636 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,200 shares for transaction amount of $4,800 was made by Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) on 2022‑08‑12.
| 2022-08-12 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 1,200 0.0445% | $4.00 | $4,800 | -27.57% | ||
| 2022-08-11 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 1,200 0.0456% | $4.03 | $4,836 | -26.08% | ||
| 2021-04-16 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 8,500 0.0366% | $1.15 | $9,809 | -30.80% | ||
| 2020-05-15 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 4,200 0.1219% | $1.21 | $5,072 | -5.00% | ||
| 2020-05-04 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 4,167 0.1136% | $1.20 | $5,000 | -9.45% | ||
| 2020-05-04 | MATSUI CONNIE | director | 41,667 1.1357% | $1.20 | $50,000 | -9.45% | ||
| 2019-11-04 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,400 0.0701% | $2.21 | $5,304 | -45.78% | ||
| 2019-11-01 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,500 0.0823% | $2.28 | $5,702 | -40.29% | ||
| 2019-10-31 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,500 0.0729% | $1.95 | $4,875 | -38.19% | ||
| 2019-10-30 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,600 0.0771% | $1.99 | $5,186 | -38.50% | ||
| 2019-10-15 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,600 0.0793% | $2.05 | $5,333 | -37.50% | ||
| 2019-10-11 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,700 0.0796% | $1.96 | $5,296 | -36.87% |
| Increased Positions | 8 | +66.67% | 84,255 | +254.99% |
| Decreased Positions | 5 | -41.67% | 18,793 | -56.87% |
| New Positions | 6 | New | 50,837 | New |
| Sold Out Positions | 5 | Sold Out | 18,793 | Sold Out |
| Total Postitions | 15 | +25% | 98,505 | +198.11% |
| Drw Securities, Llc | $22.00 | 0.86% | 17,185 | +17,185 | New | 2025-09-30 |
| Vanguard Group Inc | $18.00 | 0.7% | 14,028 | +14,028 | New | 2025-09-30 |
| Morgan Stanley | $1.00 | 0.06% | 1,100 | +1,096 | +27,400% | 2025-09-30 |
| Citigroup Inc | $1.00 | 0.02% | 477 | +468 | +5,200% | 2025-09-30 |
| Ubs Group Ag | $0 | 0.01% | 209 | +120 | +134.83% | 2025-09-30 |
| Fmr Llc | $0 | <0.01% | 30 | +29 | +2,900% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 11 | +6 | +120% | 2025-09-30 |
| Rothschild Investment Llc | $0 | 0% | 2 | +2 | New | 2025-09-30 |
| Royal Bank Of Canada | $0 | 0% | 1 | 0 | 0% | 2025-09-30 |
| Danske Bank A/S | $0 | 0% | 0 | <1 | Sold Out | 2025-09-30 |